| 000 | 01108 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250513051528.0 | ||
| 264 | 0 | _c19941006 | |
| 008 | 199410s 0 0 eng d | ||
| 022 | _a1055-9612 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJohansson, A M | |
| 245 | 0 | 0 |
_aDopamine D2 receptor agonists: an analysis of indirect models. _h[electronic resource] |
| 260 |
_bDrug design and discovery _cFeb 1994 |
||
| 300 |
_a159-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApomorphine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aBinding, Competitive _xdrug effects |
| 650 | 0 | 4 | _aCattle |
| 650 | 0 | 4 |
_aDopamine Agents _xchemistry |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aModels, Chemical |
| 650 | 0 | 4 | _aMolecular Conformation |
| 650 | 0 | 4 |
_aNeostriatum _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Dopamine D2 _xchemistry |
| 650 | 0 | 4 |
_aSpiperone _xpharmacology |
| 700 | 1 | _aGrol, C J | |
| 700 | 1 | _aKarlén, A | |
| 700 | 1 | _aHacksell, U | |
| 773 | 0 |
_tDrug design and discovery _gvol. 11 _gno. 2 _gp. 159-74 |
|
| 999 |
_c7914883 _d7914883 |
||